RNU6-1041P

Across TCGA pan-cancer cohorts, RNU6-1041P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-1041P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-1041P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1041P expression acts as an unfavorable survival marker.

BLCA, UCEC, and HNSC are the cancer types where RNU6-1041P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.192	0.611	<.001	99	view →
UCEC	OS	Tertile	III,IV	0.572	0.837	.002	78	view →
HNSC	DFS	Tertile	II,III,IV	0.203	0.618	.001	42	view →
SARC	OS	Tertile	All	0.109	0.839	<.001	36	view →
KIRP	OS	Tertile	All	0.590	0.903	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-1041P–BLCA (OS)

Open the BLCA breakdown →